Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
JAMA
|
November 25, 1988
Psychoactive medication use in intermediate-care facility residents
M Beers, J Avorn, S B Soumerai, et al.
Clinical Pharmacology and Therapeutics
|
July 15, 1998
Urinary excretion of 6 beta-hydroxycortisol as an in vivo marker for CYP3A induction: applications and recommendations
S J Kovacs, D E Martin, D E Everitt, et al.
Journal of Glaucoma
|
November 19, 2009
Patterns of glaucoma medication use in the elderly: 1980-1990
R L Bohn, R J Glynn, J H Gurwitz, et al.
American Journal of Public Health
|
May 1, 1993
Treatment for glaucoma: adherence by the elderly
J H Gurwitz, R J Glynn, M Monane, et al.
Journal of Clinical Pharmacology
|
April 1, 1997
Effect of intravenous fenoldopam on intraocular pressure in ocular hypertension
D E Everitt, S C Boike, J R Piltz-Seymour, et al.
Journal of Clinical Psychopharmacology
|
December 31, 1997
Paroxetine does not affect the cardiac safety and pharmacokinetics of terfenadine in healthy adult men
D E Martin, B D Zussman, D E Everitt, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
March 1, 1996
The impact of ibuprofen on the efficacy of antihypertensive treatment with hydrochlorothiazide in elderly persons
J H Gurwitz, D E Everitt, M Monane, et al.
Journal of Glaucoma
|
November 19, 2009
Adverse pulmonary effects of topical Beta blockers used in the treatment of glaucoma
J Avorn, R J Glynn, J H Gurwitz, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
July 22, 1998
Fenoldopam, a selective dopamine-1 receptor agonist, raises intraocular pressure in males with normal intraocular pressure
J R Piltz, R A Stone, S Boike, et al.
The Journal of Infectious Diseases
|
September 1, 1996
The pharmacokinetics, antigenicity, and fusion-inhibition activity of RSHZ19, a humanized monoclonal antibody to respiratory syncytial virus, in healthy volunteers
D E Everitt, C B Davis, K Thompson, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
JAMA
|
November 25, 1988
Psychoactive medication use in intermediate-care facility residents
M Beers, J Avorn, S B Soumerai, et al.
Clinical Pharmacology and Therapeutics
|
July 15, 1998
Urinary excretion of 6 beta-hydroxycortisol as an in vivo marker for CYP3A induction: applications and recommendations
S J Kovacs, D E Martin, D E Everitt, et al.
Journal of Glaucoma
|
November 19, 2009
Patterns of glaucoma medication use in the elderly: 1980-1990
R L Bohn, R J Glynn, J H Gurwitz, et al.
American Journal of Public Health
|
May 1, 1993
Treatment for glaucoma: adherence by the elderly
J H Gurwitz, R J Glynn, M Monane, et al.
Journal of Clinical Pharmacology
|
April 1, 1997
Effect of intravenous fenoldopam on intraocular pressure in ocular hypertension
D E Everitt, S C Boike, J R Piltz-Seymour, et al.
Journal of Clinical Psychopharmacology
|
December 31, 1997
Paroxetine does not affect the cardiac safety and pharmacokinetics of terfenadine in healthy adult men
D E Martin, B D Zussman, D E Everitt, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
March 1, 1996
The impact of ibuprofen on the efficacy of antihypertensive treatment with hydrochlorothiazide in elderly persons
J H Gurwitz, D E Everitt, M Monane, et al.
Journal of Glaucoma
|
November 19, 2009
Adverse pulmonary effects of topical Beta blockers used in the treatment of glaucoma
J Avorn, R J Glynn, J H Gurwitz, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
July 22, 1998
Fenoldopam, a selective dopamine-1 receptor agonist, raises intraocular pressure in males with normal intraocular pressure
J R Piltz, R A Stone, S Boike, et al.
The Journal of Infectious Diseases
|
September 1, 1996
The pharmacokinetics, antigenicity, and fusion-inhibition activity of RSHZ19, a humanized monoclonal antibody to respiratory syncytial virus, in healthy volunteers
D E Everitt, C B Davis, K Thompson, et al.
Page
of 4